A detailed history of Fmr LLC transactions in Gh Research PLC stock. As of the latest transaction made, Fmr LLC holds 2,966,374 shares of GHRS stock, worth $26.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,966,374
Previous 3,015,069 1.62%
Holding current value
$26.8 Million
Previous $32.1 Million 7.61%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$10.5 - $14.81 $511,297 - $721,172
-48,695 Reduced 1.62%
2,966,374 $34.6 Million
Q1 2024

May 13, 2024

SELL
$5.34 - $11.09 $650,412 - $1.35 Million
-121,800 Reduced 3.88%
3,015,069 $32.1 Million
Q4 2023

Feb 13, 2024

SELL
$5.26 - $11.04 $518,636 - $1.09 Million
-98,600 Reduced 3.05%
3,136,869 $18.2 Million
Q3 2023

Nov 13, 2023

SELL
$9.8 - $14.15 $8.73 Million - $12.6 Million
-890,996 Reduced 21.59%
3,235,469 $32.5 Million
Q2 2023

Aug 11, 2023

SELL
$7.88 - $12.74 $1.17 Million - $1.9 Million
-149,056 Reduced 3.49%
4,126,465 $49 Million
Q1 2023

May 11, 2023

SELL
$6.02 - $10.92 $1.09 Million - $1.97 Million
-180,460 Reduced 4.05%
4,275,521 $34.2 Million
Q4 2022

Feb 13, 2023

SELL
$9.2 - $13.5 $5.12 Million - $7.52 Million
-556,684 Reduced 11.11%
4,455,981 $43.3 Million
Q3 2022

Nov 10, 2022

BUY
$10.15 - $16.15 $766,010 - $1.22 Million
75,469 Added 1.53%
5,012,665 $58.2 Million
Q2 2022

Aug 12, 2022

SELL
$8.99 - $19.87 $2.39 Million - $5.27 Million
-265,298 Reduced 5.1%
4,937,196 $49.3 Million
Q1 2022

May 13, 2022

BUY
$15.48 - $23.98 $1.73 Million - $2.68 Million
111,928 Added 2.2%
5,202,494 $95.2 Million
Q4 2021

Feb 14, 2022

BUY
$14.1 - $27.9 $39.6 Million - $78.3 Million
2,806,602 Added 122.88%
5,090,566 $119 Million
Q3 2021

Nov 15, 2021

BUY
$16.51 - $23.68 $15.2 Million - $21.8 Million
922,270 Added 67.73%
2,283,964 $50.4 Million
Q2 2021

Aug 13, 2021

BUY
$19.25 - $21.73 $26.2 Million - $29.6 Million
1,361,694 New
1,361,694 $29.6 Million

Others Institutions Holding GHRS

About GH Research PLC


  • Ticker GHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,020,800
  • Market Cap $470M
  • Description
  • GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...
More about GHRS
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.